These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Clinical aspects and drug therapy of Parkinson's syndrome]. Mumenthaler M Schweiz Med Wochenschr; 1966 Apr; 96(15):479-84. PubMed ID: 4862148 [No Abstract] [Full Text] [Related]
27. Electrocochleography and its role in the diagnosis and understanding of Meniere's disease. Gibson WP; Prasher DK Otolaryngol Clin North Am; 1983 Feb; 16(1):59-68. PubMed ID: 6856312 [No Abstract] [Full Text] [Related]
29. Effect of drugs in altering susceptibility to motion sickness in aerobatics and the slow rotation room. Deane FR; Wood CD; Graybiel A Aerosp Med; 1967 Aug; 38(8):842-5. PubMed ID: 6049246 [No Abstract] [Full Text] [Related]
30. [Treatment of various forms of labyrinthine disorders]. Shvartsman NA Zh Ushn Nos Gorl Bolezn; 1970; 30(5):92-4. PubMed ID: 5521624 [No Abstract] [Full Text] [Related]
31. Allergy in relation to Meniere's syndrome, labyrinthitis, and headache. Taub SJ Eye Ear Nose Throat Mon; 1969 Sep; 48(9):550-1. PubMed ID: 5802554 [No Abstract] [Full Text] [Related]
32. Alternobaric oxygen therapy in long-term treatment of Ménière's disease. Fattori B; De Iaco G; Nacci A; Casani A; Ursino F Undersea Hyperb Med; 2002; 29(4):260-70. PubMed ID: 12797667 [TBL] [Abstract][Full Text] [Related]
33. [Meniere's disease. 1: Etiology, pathogenesis, and clinical picture]. Burian K Med Klin; 1973 May; 68(21):687-9. PubMed ID: 4715772 [No Abstract] [Full Text] [Related]
34. [Treatment of spontaneous and postoperative labyrinth disorders with Torecan]. Semczuk B; Klonowski S Pol Tyg Lek; 1969 Oct; 24(43):1658-60. PubMed ID: 5356386 [No Abstract] [Full Text] [Related]
35. Influence of amphetamine and scopolamine on the catalepsy induced by diencephalic lesions in rats. Delini-Stula A; Morpurgo C Int J Neuropharmacol; 1968 Jul; 7(4):391-4. PubMed ID: 5752934 [No Abstract] [Full Text] [Related]
36. Assessing the stage of Meniere's disease using vestibular evoked myogenic potentials. Young YH; Huang TW; Cheng PW Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):815-8. PubMed ID: 12925337 [TBL] [Abstract][Full Text] [Related]
37. [Considerations about methods to test the effectiveness of anti-vertiginous drugs (author's transl)]. Scherer H; Bschorr J Laryngol Rhinol Otol (Stuttg); 1980 Aug; 59(8):477-84. PubMed ID: 6110133 [TBL] [Abstract][Full Text] [Related]
38. [Hormone content of the blood in Ménière's disease and cochleovestibulopathy]. Buianovskaia OA; Potemkin VV; Gudukina GN Vestn Otorinolaringol; 1982; (3):40-4. PubMed ID: 6285577 [No Abstract] [Full Text] [Related]
39. [Etiology and pathogenesis of Menière's disease in association with meteorotropic processes]. Hanicke O HNO; 1968 Oct; 16(10):298-302. PubMed ID: 4881825 [No Abstract] [Full Text] [Related]
40. The differential diagnosis of Meniere's disease. Weber PC; Adkins WY Otolaryngol Clin North Am; 1997 Dec; 30(6):977-86. PubMed ID: 9386235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]